Aurora Cannabis (ACB) Receivables - Other (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Receivables - Other of $747435.8 for Q1 2026, down 61.42% year-on-year from $1.9 million in Q1 2025, and down 61.42% on a QoQ basis from $1.9 million in Q1 2025.
Aurora Cannabis (ACB) Receivables - Other (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Receivables - Other for 10 consecutive years, with $747435.8 the latest figure, recorded in Q1 2026.
- Quarterly Receivables - Other fell 61.42% year-over-year to $747435.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $747435.8 (down 61.42% YoY) and the FY2026 annual result came in at $741699.9, down 62.91% from the prior year.
- Receivables - Other slipped to $747435.8 in Q1 2026 per ACB's latest filing, from $1.9 million in the prior quarter.
- Over the last five years, Receivables - Other for ACB reached as high as $1.9 million in Q1 2025 and fell as low as $666417.7 in Q1 2024.
- A 5-year average of $966726.5 and a median of $808446.1 in 2023 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2022 — Receivables - Other sank 64.03% — and 2025, when it soared 190.72%.
- Year by year, Receivables - Other stood at $832185.4 in 2022, then dropped by 4.19% to $797308.6 in 2023, then declined by 16.42% to $666417.7 in 2024, then surged by 190.72% to $1.9 million in 2025, then tumbled by 61.42% to $747435.8 in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $747435.8, $1.9 million, and $666417.7 for Q1 2026, Q1 2025, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 747,435.83 |
| Mar 31, 2026 | 747,435.83 |
| Mar 31, 2025 | 1.94 Mn |
| Mar 31, 2025 | 1.94 Mn |
| Mar 31, 2024 | 666,417.66 |
| Mar 31, 2024 | 666,417.66 |
| Jun 30, 2023 | 797,308.59 |
| Jun 30, 2023 | 797,308.59 |
| Mar 31, 2023 | 819,583.57 |
| Mar 31, 2023 | 819,583.57 |
| Jun 30, 2022 | 832,185.43 |
| Jun 30, 2022 | 832,185.43 |
| Jun 30, 2021 | 2.31 Mn |
| Jun 30, 2021 | 2.31 Mn |
| Jun 30, 2020 | 2.34 Mn |
| Jun 30, 2020 | 2.34 Mn |
| Jun 30, 2019 | 1.01 Mn |
| Jun 30, 2019 | 1.01 Mn |
| Mar 31, 2019 | 4.54 Mn |
| Mar 31, 2019 | 4.54 Mn |